EDGE
Book a demo

All Updates

Filter
This week:
Funding
Rgenta Therapeutics raises USD 52 million in a Series A funding
Precision Medicine
Nov 29
Funding
Cajal Neuroscience raises USD 96 million in Series A funding; launches from stealth
Precision Medicine
Nov 29
Last week:
Funding
Hemispherian raises USD 2.9 million in Series A funding
Precision Medicine
Nov 24
Listing
NewAmsterdam Pharma concludes SPAC merger; new entity lists on NASDAQ
Precision Medicine
Nov 23
Funding
Tenanya closes underwritten public offering at USD 75 million
Precision Medicine
Nov 22
Funding
Opna Bio raises USD 38 million in Series A funding; launches from stealth
Precision Medicine
Nov 21
Funding
FogPharma raises USD 178 million in a Series D funding
Precision Medicine
Nov 21
Funding
Tenaya Therapeutics plans USD 75 million in public offering
Precision Medicine
Nov 16
Funding
Haystack Oncology raises USD 56 in a Series A funding
Precision Medicine
Nov 16
Funding
Acrivon Therapeutics plans USD 99.4 million IPO; to be listed on Nasdaq Global Market
Precision Medicine
Nov 15
Management news
Illumina retrench 5% of its global staff to mitigate macroeconomic challenges
Precision Medicine
Nov 15
Partnerships
Funding
Jnana Therapeutics raises USD 107 million in Series C funding; partners with Roche for drug development
Precision Medicine
Nov 15
Earnings/results
SomaLogic beats analyst estimates in Q3 2022
Precision Medicine
Nov 14
Earnings/results
Sema4 continues restructuring Q3 2022; revenue doubles YoY
Precision Medicine
Nov 14
Earnings/results
Chinook Therapeutics misses analyst estimates in Q3 2022; widen net losses
Precision Medicine
Nov 11
Earnings/results
Tenaya Therapeutics misses analyst expectations; extends cash runway till mid-2024
Precision Medicine
Nov 11
Earnings/results
Prometheus Biosciences reports wider losses in Q3 2022; extends cash runway till 2024
Precision Medicine
Nov 10
Earnings/results
Monte Rosa Therapeutics beats analysis consensus in Q3 2022; extends its cash runway till late 2024
Precision Medicine
Nov 10
Earnings/results
Tango Therapeutics misses analyst expectations in Q3 2022; reports wider losses
Precision Medicine
Nov 10
Funding
Nabsys raises USD 13 million in an extended equity round
Precision Medicine
Nov 10
Earnings/results
Kinnate Biopharma misses analyst estimates in Q3 2022; extends cash runway till mid-2024
Precision Medicine
Nov 10
Earnings/results
Invitae beats analyst consensus in Q3 2022; losses narrow with revenue growth
Precision Medicine
Nov 9
Earnings/results
Mirati Therapeutics beats analyst consensus in Q3 2022; reports weaker earnings amid preperations for commercial launch of lead drug candidate
Precision Medicine
Nov 9
Funding
NRG Therapeutics raises USD 16 million in Series A funding
Precision Medicine
Nov 9
Earnings/results
Praxis Precision Medicines misses analyst estimates in Q3 2022; plans phase 3 clinical trial for lead candidate in mid-2023
Precision Medicine
Nov 9
Funding
BC Platforms raises USD 20 million in funding
Precision Medicine
Nov 8
Earnings/results
Fulcrum Therapeutics beats analyst consensus in Q3 2022; extends cash runway till 2024
Precision Medicine
Nov 8
Earnings/results
Black Diamond Therapeutics beats analyst expectations in Q3 2022; extends cash runway till Q3 2024
Precision Medicine
Nov 8
Earnings/results
IDEAYA Biosciences beats analyst expectations in Q3 2022, reports net income with strong revenue growth
Precision Medicine
Nov 8
Earnings/results
23andMe misses analysts estimates; reports marginal losses in Q2 of FY2023
Precision Medicine
Nov 7
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.